COVID-19 blood clot mystery: new study reveals clotting risks in severe cases
NCT ID NCT04356950
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 27 times
Summary
This study examined blood clotting issues in 175 hospitalized COVID-19 patients. Researchers measured how well the blood forms clots (thrombin generation) to see if these tests could predict survival. The goal was to better understand why severe COVID-19 causes dangerous clotting, which could help guide future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Bordeaux
Bordeaux, France
-
CHU de Limoges
Limoges, France
-
CHU de Montpellier
Montpellier, France
-
CHU de Nimes
Nîmes, France
Conditions
Explore the condition pages connected to this study.